EcoDrugPlus

26s Protease Regulatory Subunit 10b-Like

Ensembl ID : ENSNBRG00000014031
Gene Symbol: LOC102777855
3 Cross references
242 Possible Orthologues:

26s Protease Regulatory Subunit 6a-Like

Ensembl ID : ENSNBRG00000004143
Gene Symbol: LOC102775856
3 Cross references
226 Possible Orthologues:

26s Protease Regulatory Subunit 6b-Like

Ensembl ID : ENSNBRG00000021805
Gene Symbol: LOC102786645
3 Cross references
197 Possible Orthologues:

26s Protease Regulatory Subunit 7-Like

Ensembl ID : ENSNBRG00000009236
Gene Symbol: LOC102779335
3 Cross references
232 Possible Orthologues:

26s Protease Regulatory Subunit 8-Like

Ensembl ID : ENSNBRG00000012673
Gene Symbol: LOC102777430
3 Cross references
228 Possible Orthologues:

26s Proteasome Complex Subunit Dss1-Like

Ensembl ID : ENSNBRG00000006187
Gene Symbol: LOC102798319
3 Cross references
155 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 1-Like

Ensembl ID : ENSNBRG00000020658
Gene Symbol: LOC102787356
3 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b-Like

Ensembl ID : ENSNBRG00000023279
Gene Symbol: LOC102783508
3 Cross references
220 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 12-Like

Ensembl ID : ENSNBRG00000000058
Gene Symbol: LOC102799019
3 Cross references
220 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 13-Like

Ensembl ID : ENSNBRG00000015302
Gene Symbol: LOC102787502
3 Cross references
216 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 14-Like

Ensembl ID : ENSNBRG00000020254
Gene Symbol: LOC102791553
3 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSNBRG00000005781
Gene Symbol: LOC102785350
3 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).